2487573-01-1: Apremilast Impurity 17

Apremilast Impurity 17 (CAS NO.-2487573-01-1) IUPAC Name-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-((2-hydroxyethyl)sulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide. Apremilast is an oral phosphodiesterase 4 inhibitors that have an impact on a wide range of inflammatory mediators involved in psoriasis and psoriatic arthritis, this is the novel treatment that focuses on maintaining a balance between pro-inflammatory and anti-inflammatory signals.

Additional information

Catalogue No.

VE008026

CAS No.

2487573-01-1

Molecular Formula

C23H26N2O8S

Molecular Weight

490.54 g/mol

IUPAC Name

N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-((2-hydroxyethyl)sulfonyl)ethyl)-1, 3-dioxoisoindolin-4-yl)acetamide

References

Schafer, Peter. “Apremilast Mechanism of Action and Application to Psoriasis and Psoriatic Arthritis.” Biochemical Pharmacology, vol. 83, no. 12, June 2012, pp. 1583–90, https://doi.org/10.1016/j.bcp.2012.01.001.

Status

In-stock